Navigation Links
Greater Amplification Specificity with New Hot Start PCR Enzyme

he target from 500 and 5000 copies of HIV-1 template, nonspecific products predominated in reactions using 5, 50, and 500 copies (Figure 2). In contrast, SureStart Taq DNA polymerase produced specific amplification product from as few as five copies of DNA template, and no background was visible (Figure 2).

In Figure 3, a 970-bp fragment was amplified from 101 to 105 copies of lambda DNA in the absence or presence of 0.5 mg of denatured genomic DNA. In a complex DNA sample, multiple nonspecific products were generated, and specific product yield was reduced (Figure 3A). When compared to Taq, SureStart Taq DNA polymerase successfully amplified the desired product from as few as 101 copies of lambda DNA, even in the presence of high concentrations of extraneous denatured DNA. Moreover, SureStart Taq DNA polymerase generated far fewer nonspecific products compared to Taq DNA polymerase. Comparisons with other vendors hot start enzymes showed similar improvements in specific product yield (Figure 3B, Lanes 1 to 3) but high background was evident in two of the three hot start preparations tested.

Conclusions

Use Stratagenes SureStart Taq DNA polymerase to achieve a simple and effective method for hot start. SureStart Taq DNA polymerase improves the sensitivity of amplification reactions by reducing background and increasing yield of desired product. Compared to other vendors hot start Taq preparations, SureStart Taq provides comparable or superior detection of low-copy-number targets. SureStart Taq is inactive at ambient temp
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Enjoy a Greater Sense of Security with PCR-Grade Water
2. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
3. Simple Purification of DNA from Plasmid Minipreps, PCR Amplifications and Agarose Gels
4. Enhanced Amplification of Long Targets with PfuTurbo DNA Polymerase
5. Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer
6. Improve Amplification Specificity with Hot Start PCR Enzyme
7. Amplification of the amoA Gene of Nitrosococcus oceani Bacteria Using Eppendorf MasterTaq
8. Amplification of Mouse cDNAs for Microarrays Using the Eppendorf MasterTaq Kit
9. Optimizing the Direct Amplification of Missing cDNA 5 Ends Using the Eppendorf Mastercycler gradient
10. Optimizing DNA Amplification Protocols using the Eppendorf Mastercycler
11. Amplification of Epstein-Barr Virus Exon C with Difficult Primers Using Eppendorf Mastercycler gradient
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Greater Amplification Specificity with New Hot Start PCR Enzyme

(Date:3/16/2010)... , TAMPA, Fla. (March 16, 2010)Approximately half of Americans ... some point during the course of their disease. Radiofrequency ... in the tumor causing cancer cell death with minimal ... prolongation of their life by nearly three years, note ...
(Date:3/16/2010)... , Santa Fe, NM, USA -- March 12, 2010A Materials ... Hector, Jr. of the General Motors R&D Center, has been ... on:, , Fundamentals of Interfacial Tribology, Multi-scale Modeling of ... named in honor of John M. Campbell, a former scientific ...
(Date:3/16/2010)... DIEGO , March 16  Neurocrine Biosciences, Inc. (Nasdaq: ... recently completed public offering of common stock has exercised in ... common stock to cover over-allotments.  The sale of the additional ... into account the sale of the additional shares at a ...
(Date:3/16/2010)... , March 16 /PRNewswire-FirstCall/ - DDS Technologies USA, Inc. (DDSU; www.ddstechnologiesusa.com ) had retained the Mina Mar Group ( http://www.minamargroup.com/ ) as forefront representative of the company,s ... ... ... ...
Breaking Biology Technology:Living longer: Colon cancer patients gain time with radiofrequency ablation treatment 2Living longer: Colon cancer patients gain time with radiofrequency ablation treatment 3Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering 2Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering 3DDS Technologies USA, Inc. (DDSU) Appoints Mina Mar Group as Its Corporate Advisor for a Merger 2DDS Technologies USA, Inc. (DDSU) Appoints Mina Mar Group as Its Corporate Advisor for a Merger 3DDS Technologies USA, Inc. (DDSU) Appoints Mina Mar Group as Its Corporate Advisor for a Merger 4DDS Technologies USA, Inc. (DDSU) Appoints Mina Mar Group as Its Corporate Advisor for a Merger 5DDS Technologies USA, Inc. (DDSU) Appoints Mina Mar Group as Its Corporate Advisor for a Merger 6
... China Agritech, Inc.,(OTC Bulletin Board: CAGC) ("China Agritech" ... in China, today announced that it,has entered into ... of AL Ezz,Group, a distributor of agricultural and ... AL Ezz Group began working with China Agritech ...
... for Therapeutic and Diagnostic ... ... (Nasdaq: SIAL ) and Sangamo BioSciences, Inc.,(Nasdaq: SGMO ) ... with non-exclusive, worldwide rights for the use of its,proprietary zinc finger ...
... July 9 Epeius Biotechnologies,Corporation today announced that ... U.S. Food and Drug Administration (FDA) for the,treatment ... is the third,clinical indication for which Rexin-G has ... States. This latest approval for Rexin-G validates the,company,s ...
Other Biology Technology:China Agritech to Export Products to Egypt 2China Agritech to Export Products to Egypt 3Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals 2Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals 3Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals 4Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals 5FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 2FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 3
(Date:3/17/2010)... , , University of Chicago scientists have successfully used geometrically ... The new approach is a departure from that of ... role of proteins in controlling the fate of stem ... proteins. In both cases it,s the shape alone that,s ...
(Date:3/17/2010)... . , A team of McGill Chemistry Department researchers led ... development of nanotubes tiny "magic bullets" that could one day ... involves taking DNA out of its biological context. So rather than ... kind of building block for tiny nanometre-scale objects. , Using ...
(Date:3/17/2010)... Arctic,s biodiversity reports a 26 per cent decline in species ... and red knot are some of the species that have ... first report from The Arctic Species Trend Index (ASTI), which ... are responding to environmental change. , While some of these ...
Breaking Biology News(10 mins):High Arctic species on thin ice 2ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 1ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 2ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 3ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 4Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796 Broad Spectrum Oral and IV Antibiotic in Phase 3 5318 1Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796 Broad Spectrum Oral and IV Antibiotic in Phase 3 5318 2Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796 Broad Spectrum Oral and IV Antibiotic in Phase 3 5318 3Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 14393 1Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 14393 2
... from CT scans of fossils locked inside rocks may flip ... backbones were known to have moved from fish to landlubber. ... an estimated 360-370 million years ago in what is now ... tetrapod, that is, the first vertebrate animal to possess limbs ...
... women astronauts, Bonnie J. Dunbar, now a flight museum president, will ... invited to attend this exciting free event during which Dunbar will ... , The event will be held at 11:30 a.m., ... sponsors include Purdue Pharma L.P. and Bristol-Myers Squibb Company. , ...
... ORLEANSThe connection between the body, mind and spirit has ... 20 years. The notion that psychosocial and societal considerations ... became crystallized as a result of the experiences of ... a writer and magazine editor of the popular Saturday ...
Other Biology News:Fossils suggest earlier land-water transition of tetrapod 2Fossils suggest earlier land-water transition of tetrapod 3Former NASA astronaut Bonnie J. Dunbar to speak at NJIT's biomedical engineering seminar 2Laughter remains good medicine 2Laughter remains good medicine 3
... The EC105 power supply is a highly ... supply. A single adjustment knob and one hi-lo ... in 10 volt increments from 20 to 250 ... display from indicating output voltage to output current. ...
... The EC570-90 is a compact, lightweight, high ... 500 volts or 2500 milliamps. It is an ... RNA submarine gels. It is also ideal for ... time can be set to automatically end a ...
Rat Hepatocytes (RH) (>3,000,000 cells)...
QCPN...
Biology Products: